Resultats de la cerca - Ram Kalpatthi

  • Mostrar 1 - 7 resultats de 7
Refinar resultats
  1. 1
    Long‐term use of the thrombopoietin‐mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)

    Long‐term use of the thrombopoietin‐mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP) per James B. Bussel, Loan Hsieh, George R. Buchanan, Kimo C. Stine, Ram Kalpatthi, David J. Gnarra, Richard Ho, Kun Nie, Melissa Eisen

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Developmental Function in Toddlers With Sickle Cell Anemia

    Developmental Function in Toddlers With Sickle Cell Anemia per F. Daniel Armstrong, T. David Elkin, R. Clark Brown, Penny Glass, Sohail Rana, James F. Casella, Ram Kalpatthi, Steven G. Pavlakis, Zhibao Mi, Winfred C. Wang

    Publicat 2013
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Immunologic Effects of Hydroxyurea in Sickle Cell Anemia

    Immunologic Effects of Hydroxyurea in Sickle Cell Anemia per Howard M. Lederman, Margaret A. Connolly, Ram Kalpatthi, Russell E. Ware, Winfred C. Wang, Lori Luchtman‐Jones, Myron A. Waclawiw, Jonathan C. Goldsmith, Andrea J. Swift, James F. Casella

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Impact of hydroxyurea on clinical events in the BABY HUG trial

    Impact of hydroxyurea on clinical events in the BABY HUG trial per Courtney D. Thornburg, Beatrice Files, Zhaoyu Luo, Scott T. Miller, Ram Kalpatthi, Rathi V. Iyer, Phillip Seaman, Jeffrey D. Lebensburger, Ofelia Álvarez, Bruce Thompson, Russell E. Ware, Winfred C. Wang

    Publicat 2012
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years

    Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years per Jeremie H. Estepp, Ram Kalpatthi, Gerald M. Woods, Sara Trompeter, Robert I. Liem, Kacie Sims, Adlette Inati, Baba Inusa, Andrew Campbell, Connie M. Piccone, Miguel R. Abboud, Kim Smith‐Whitley, Sandra Dixon, Margaret Tonda, Carla Washington, Noelle M. Griffin, R. Clark Brown

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design

    The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design per Bruce Thompson, Scott T. Miller, Zora R. Rogers, Renée C. Rees, Russell E. Ware, Myron A. Waclawiw, Rathi V. Iyer, James F. Casella, Lori Luchtman‐Jones, Sohail Rana, Courtney D. Thornburg, Ram Kalpatthi, Julio C. Barredo, R. Clark Brown, Sharada A. Sarnaik, Thomas H. Howard, Lori Luck, Winfred C. Wang

    Publicat 2009
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

    Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) per Winfred C. Wang, Russell E. Ware, Scott T. Miller, Rathi V. Iyer, James F. Casella, Caterina P. Minniti, Sohail Rana, Courtney D. Thornburg, Zora R. Rogers, Ram Kalpatthi, Julio C. Barredo, R. Clark Brown, Sharada A. Sarnaik, Thomas H. Howard, Lynn Wynn, Abdullah Kutlar, F. Daniel Armstrong, Beatrice Files, Jonathan C. Goldsmith, Myron A. Waclawiw, Xiangke Huang, Bruce Thompson

    Publicat 2011
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: